0001757971-18-000001.txt : 20181102 0001757971-18-000001.hdr.sgml : 20181102 20181101212757 ACCESSION NUMBER: 0001757971-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181102 DATE AS OF CHANGE: 20181101 EFFECTIVENESS DATE: 20181102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rekindle Therapeutics Inc. CENTRAL INDEX KEY: 0001757971 IRS NUMBER: 830901060 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-324935 FILM NUMBER: 181155381 BUSINESS ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6176690509 MAIL ADDRESS: STREET 1: 450 KENDALL STREET STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 D 1 primary_doc.xml X0708 D LIVE 0001757971 Rekindle Therapeutics Inc. 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02142 6176690509 DELAWARE None None Corporation true 2018 Detlev Biniszkiewicz 450 Kendall Street 5th Floor Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Ed Hurwitz 450 Kendall Street 5th Floor Cambridge MA MASSACHUSETTS 02142 Director Bard Geesaman 450 Kendall Street 5th Floor Cambridge MA MASSACHUSETTS 02142 Director Biotechnology Decline to Disclose 06b false 2018-10-17 false true false 10000 6500000 1100000 5400000 false 4 0 true 0 true 0 true false Rekindle Therapeutics Inc. Paul Sweeney Paul Sweeney Assistant Secretary 2018-11-01